NK-92 cells retain vitality and functionality when grown in standard cell culture conditions

PLoS One. 2022 Mar 16;17(3):e0264897. doi: 10.1371/journal.pone.0264897. eCollection 2022.

Abstract

NK-92 cells are an off-the-shelf, cell-based immunotherapy currently in clinical trials for a variety of cancer types. As the most 'NK-like' cell line available, it is also an important research tool. To date, NK-92 cells have been cultivated in a costly and time-consumingly prepared specialized medium, complicating research with these cells. Here we show that NK-92 cells grow in the comparatively user-friendly RPMI medium supplemented with IL-2. We demonstrate that their metabolic activity and replication rates are even improved in RPMI. Furthermore, they can be grown in cell culture dishes and do not need to be expanded in ventilated flasks. We show that in RPMI the cells retain functional characteristics relating to receptor expression, IFN-γ secretion, and killing. Our findings will enable more researchers to work with and manipulate this cell line, hopefully leading to further discoveries and improved therapies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Culture Techniques
  • Culture Media / metabolism
  • Cytotoxicity, Immunologic*
  • Humans
  • Immunotherapy
  • Killer Cells, Natural / metabolism
  • Neoplasms* / metabolism
  • Neoplasms* / therapy

Substances

  • Culture Media

Grants and funding

R. K. was awarded the H2020-MSC_ITN_765104_MATURE-NK grant from the European Commision http://www.mature-nk.eu. Furthermore, the work was funded by the Israel Innovation Authority Kamin grant 62615 http://innovation-israel-en.mag.calltext.co.il, the Israeli Science Foundation ISF Moked grant 442-18 https://www.isf.org.il/#/, the German-Israeli Foundation for Scientific Research and Development grant 1412-414.13/2017 http://www.gif.org.il/Pages/default.aspx, ICRF Professorship grant Israeli Cancer Research Fund https://www.icrfonline.org/grants/, the Israeli Science Foundation ISF China grant 2554/18 https://www.isf.org.il/#/, the Ministry of Science and Technology Foundation - Deutsches Krebsforschungszentrum MOST-DKFZ grant 3-14931 https://www.trdf.co.il/eng/kolkoreinfo.php?id=8571, the Ministry of Science and Technology grant 3-14764 https://www.gov.il/he/Departments/ministry_of_science_and_technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.